Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biocept, Inc. (BIOCQ)
:BIOCQ
Holding BIOCQ?
Track your performance easily
BIOCQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.00 - $0.13
Previous CloseN/A
Volume3.00
Average Volume (3M)1.02K
Market Cap
$263.00
Enterprise ValueN/A
Total Cash (Recent Filing)$4.61M
Total Debt (Recent Filing)$1.90M
Price to Earnings (P/E)―
Beta-142.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,626,026
10 Day Avg. Volume2
30 Day Avg. Volume1,023
Standard Deviation645.20
R-Squared0.00
Alpha86.52
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
5.00% Other Institutional Investors
95.00% Public Companies and
Individual Investors
BIOCQ FAQ
What was Biocept, Inc.’s price range in the past 12 months?
Biocept, Inc. lowest stock price was $0.00 and its highest was $0.13 in the past 12 months.
What is Biocept, Inc.’s market cap?
Biocept, Inc.’s market cap is $263.00.
When is Biocept, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biocept, Inc.’s earnings last quarter?
Currently, no data Available
Is Biocept, Inc. overvalued?
According to Wall Street analysts Biocept, Inc.’s price is currently Overvalued.
Does Biocept, Inc. pay dividends?
Biocept, Inc. does not currently pay dividends.
What is Biocept, Inc.’s EPS estimate?
Biocept, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biocept, Inc. have?
Biocept, Inc. has 2,626,026 shares outstanding.
What happened to Biocept, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Biocept, Inc.?
Currently, no hedge funds are holding shares in BIOCQ
---
Company Description
Biocept, Inc.
Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.
---
OncoCyte
―
VolitionRX
―
Myriad Genetics
―
Fulgent Genetics
―
Qualigen Therapeutics
―
Advaxis
―
---